David W. Dougherty, MD, MBA, is an Innovation Faculty member at the Penn Center for Cancer Care Innovation and the Deputy Director of Clinical Services at the Abramson Cancer Center and Cancer Service Line. Dr. Dougherty is an expert in cancer care delivery, quality and equity, finance and payors, electronic health records, and community-based clinical trials. He is a board-certified medical oncologist and a practicing specialist in the care of patients with thoracic cancers at the Hospital of the University of Pennsylvania.

Dr. Dougherty was most recently the Medical Director of the Dana-Farber Cancer Institute Network in Boston, where he oversaw the clinical care and research operations across the Dana-Farber satellite sites. For several years prior to joining the Dana Farber, he was a leader at the Wilmot Cancer Institute at Rochester, serving as Chief Quality Officer and Director of Regional Operations. Dr. Dougherty has also been active in the quality of care efforts for the American Society of Clinical Oncology, previously serving as chair of the Quality Oncology Practice Initiative Certification Program Committee and, currently, as chair of the Joint Certifications Committee. Dr. Dougherty’s research interests focus on cancer care delivery and improving value of care for patients with cancer and their caregivers, including quality, economic burden, patient-reported outcomes, and patient-oncologist communication.

A graduate of the Pennsylvania State University, Dr. Dougherty earned his medical degree from Jefferson Medical College and completed his internal medicine residency and chief residency at Penn State Milton S. Hershey Medical Center. He completed fellowship in oncology at the University of Rochester Medical Center and earned his MBA from the University of Rochester Simon School of Business.